Yahoo Web Search

  1. As capital comes back home to the U.S., we are seeing President Trump’s tax reform pay off bigly for our country. U.S.-based Pfizer this week announced that it will combine its off-patent drug ...

  2. Medical aesthetics company Evolus Inc on Monday beat Wall Street estimates for second-quarter revenue from its newly launched rival to Allergan Plc's Botox, which has dominated ...

  3. Goldman Warns Hedge Fund Outperformance Holds Crowding Risk

    Bloomberg via Yahoo FinanceAug 21 17:11 PM

    Funds have benefited from both a rising stock market and successful stock selection, strategists including Ben Snider and David Kostin wrote in a note Aug. 20. They’ve also concentrated their ...

  4. Who is next in big pharma's merger spree?

    Reuters via Yahoo FinanceAug 19 19:20 PM

    Bristol-Myers Squibb's $74 billion acquisition of Celgene set the M&A ball rolling in January, and was followed by AbbVie Inc's $63 billion bid for troubled smaller rival Allergan Plc ...

  5. Endo International Plc and Allergan Plc have agreed to pay $15 million to avoid going to trial in October in a landmark case by two Ohio counties accusing various drug manufacturers ...

  6. Argentina Apoplexy, IPOs and Other Things to Watch on 13F Day

    Bloomberg via Yahoo FinanceAug 13 21:58 PM

    Managers including Autonomy Capital’s Robert Gibbins and Pointstate Capital’s Zach Schreiber started the year with bets on Argentine companies that trade in the U.S. After hedge funds finish ...

  7. PRESS DIGEST- Wall Street Journal - Aug 20

    Reuters via Yahoo FinanceAug 20 5:07 AM

    Kong, marking the first time the companies have pointed to China as a source of disinformation campaigns, company representatives said on Monday. - Drugmakers Endo International Plc and ...

  8. Humira brought in global revenue of $4.87 billion in the second quarter, but sales have been hit by competition from cheaper rivals in Europe, and AbbVie in June announced a deal to buy Botox-maker ...

  9. The latest round of 13F filings from institutional investors were out this week, revealing to the world the stocks that some of the richest and most successful investors have been buying and ...

  10. Drug distributor Cardinal Health Inc warned on Tuesday that its business could be hurt as it defends itself against several opioid-related lawsuits. Several pharmaceutical wholesale distributors ...